Clinical Trials Browser

Phase 2 × aflibercept × Other hematologic neoplasm × Clear all

NCT00509249 2015-01-08

Aflibercept in Treating Patients With Myelodysplastic Syndromes

Phase 2 Terminated

18 enrolled 4 charts

MyeloidOther hematologic neoplasm

Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT00601991 2013-04-02

A Multi-Center Phase 2 Study of VEGF Trap as a Single Agent in Acute Myeloid Leukemia

Phase 2 Withdrawn

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute